Literature DB >> 31772997

A Technical Guide for Passive Scattering Proton Radiation Therapy for Breast Cancer.

Julie A Bradley1, Meng Wei Ho1, Zuofeng Li1, Xiaoying Liang1, Michael Rutenberg1, Roi Dagan1, Nancy P Mendenhall1.   

Abstract

Most patients treated with proton therapy have had eye tumors, sarcomas, or, more recently, pediatric, or prostate cancers. As more proton centers have developed globally, increased capacity will permit exploration of other potential indications for proton therapy, including for the treatment of breast cancer. The rationale for proton therapy in the treatment of breast cancer is reduced inadvertent radiation dose to the heart and lung, as well as improved target coverage. As with any new technology, multiple technical parameters require optimization to deliver safe and effective radiation therapy and to maximize the benefits of the new technology. The purpose of this report is to provide a technical guide for the treatment of breast cancer with passive-scattering proton therapy and an algorithm for selecting patients with breast cancer who would benefit from proton therapy. © Copyright 2017 International Journal of Particle Therapy.

Entities:  

Year:  2017        PMID: 31772997      PMCID: PMC6871562          DOI: 10.14338/IJPT-16-00025.1

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN: 2331-5180


  33 in total

1.  Delineation of Supraclavicular Target Volumes in Breast Cancer Radiation Therapy.

Authors:  Lindsay C Brown; Felix E Diehn; Judy C Boughey; Stephanie K Childs; Sean S Park; Elizabeth S Yan; Ivy A Petersen; Robert W Mutter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-28       Impact factor: 7.038

2.  First Clinical Investigation of Cone Beam Computed Tomography and Deformable Registration for Adaptive Proton Therapy for Lung Cancer.

Authors:  Catarina Veiga; Guillaume Janssens; Ching-Ling Teng; Thomas Baudier; Lucian Hotoiu; Jamie R McClelland; Gary Royle; Liyong Lin; Lingshu Yin; James Metz; Timothy D Solberg; Zelig Tochner; Charles B Simone; James McDonough; Boon-Keng Kevin Teo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-04       Impact factor: 7.038

3.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

Authors:  M Overgaard; M B Jensen; J Overgaard; P S Hansen; C Rose; M Andersson; C Kamby; M Kjaer; C C Gadeberg; B B Rasmussen; M Blichert-Toft; H T Mouridsen
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

Review 4.  Cardiac Side-effects From Breast Cancer Radiotherapy.

Authors:  C W Taylor; A M Kirby
Journal:  Clin Oncol (R Coll Radiol)       Date:  2015-06-28       Impact factor: 4.126

5.  Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.

Authors:  Sarah C Darby; Paul McGale; Carolyn W Taylor; Richard Peto
Journal:  Lancet Oncol       Date:  2005-08       Impact factor: 41.316

6.  Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons.

Authors:  Julie A Bradley; Roi Dagan; Meng Wei Ho; Michael Rutenberg; Christopher G Morris; Zuofeng Li; Nancy P Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-09-25       Impact factor: 7.038

7.  Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial.

Authors:  Shannon M MacDonald; Sagar A Patel; Shea Hickey; Michelle Specht; Steven J Isakoff; Michele Gadd; Barbara L Smith; Beow Y Yeap; Judith Adams; Thomas F Delaney; Hanne Kooy; Hsiao-Ming Lu; Alphonse G Taghian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-03-21       Impact factor: 7.038

8.  DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer.

Authors:  Lise Bech Jellesmark Thorsen; Birgitte Vrou Offersen; Hella Danø; Martin Berg; Ingelise Jensen; Anders Navrsted Pedersen; Sune Jürg Zimmermann; Hans-Jürgen Brodersen; Marie Overgaard; Jens Overgaard
Journal:  J Clin Oncol       Date:  2015-11-23       Impact factor: 44.544

9.  Phase II trial of proton beam accelerated partial breast irradiation in breast cancer.

Authors:  Ji Hyun Chang; Nam Kwon Lee; Ja Young Kim; Yeon-Joo Kim; Sung Ho Moon; Tae Hyun Kim; Joo-Young Kim; Dae Yong Kim; Kwan Ho Cho; Kyung Hwan Shin
Journal:  Radiother Oncol       Date:  2013-07-25       Impact factor: 6.280

10.  Dosimetric evaluation of critical organs at risk in mastectomized left-sided breast cancer radiotherapy using breath-hold technique.

Authors:  Ferrat Dincoglan; Murat Beyzadeoglu; Omer Sager; Kaan Oysul; Yelda Elcim Kahya; Hakan Gamsiz; Bora Uysal; Selcuk Demiral; Bahar Dirican; Serdar Surenkok
Journal:  Tumori       Date:  2013 Jan-Feb
View more
  3 in total

1.  Hyperfractionated-Accelerated Reirradiation with Proton Therapy for Radiation-Associated Breast Angiosarcoma.

Authors:  Wen Shen Looi; Julie A Bradley; Xiaoying Liang; Christiana M Shaw; Mark Leyngold; Raymond B Mailhot Vega; Eric D Brooks; Michael S Rutenberg; Lisa R Spiguel; Fantine Giap; Nancy P Mendenhall
Journal:  Int J Part Ther       Date:  2022-01-18

Review 2.  Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee.

Authors:  Robert W Mutter; J Isabelle Choi; Rachel B Jimenez; Youlia M Kirova; Marcio Fagundes; Bruce G Haffty; Richard A Amos; Julie A Bradley; Peter Y Chen; Xuanfeng Ding; Antoinette M Carr; Leslie M Taylor; Mark Pankuch; Raymond B Mailhot Vega; Alice Y Ho; Petra Witt Nyström; Lisa A McGee; James J Urbanic; Oren Cahlon; John H Maduro; Shannon M MacDonald
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-05-25       Impact factor: 8.013

3.  Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life.

Authors:  Alexander D Sherry; Dario Pasalic; G Brandon Gunn; C David Fuller; Jack Phan; David I Rosenthal; William H Morrison; Erich M Sturgis; Neil D Gross; Maura L Gillison; Renata Ferrarotto; Adel K El-Naggar; Adam S Garden; Steven J Frank
Journal:  Int J Part Ther       Date:  2021-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.